No Difference in Perioperative Outcomes Following Colorectal Cancer Resection Between Flagship and Non-Flagship Hospitals in New York State.

IF 2 3区 医学 Q3 ONCOLOGY Journal of Surgical Oncology Pub Date : 2024-11-28 DOI:10.1002/jso.27949
Joseph C L'Huillier, Joseph D Boccardo, Miranda Berkebile, John M Woodward, Jessica L Martinolich, Katia Noyes, Nader D Nader, Csaba Gajdos
{"title":"No Difference in Perioperative Outcomes Following Colorectal Cancer Resection Between Flagship and Non-Flagship Hospitals in New York State.","authors":"Joseph C L'Huillier, Joseph D Boccardo, Miranda Berkebile, John M Woodward, Jessica L Martinolich, Katia Noyes, Nader D Nader, Csaba Gajdos","doi":"10.1002/jso.27949","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hospitals are rapidly consolidating to create large healthcare systems. Whether outcomes following colorectal cancer resection at flagship hospitals differ from those at non-flagship hospitals is unknown.</p><p><strong>Methods: </strong>A 6-year retrospective analysis of an all-payor New York State (NYS) hospital database was conducted. All adult patients with a colorectal resection for primary resectable colorectal cancer were included. Within each system, the hospital with the most colorectal resections was designated the \"flagship\" hospital. Thirty-day outcomes at flagship facilities were compared to affiliated, non-flagship hospitals following colorectal resection while matching for patient-level differences.</p><p><strong>Results: </strong>In total, 28 400 patients were included across 31 healthcare systems in NYS. There were no differences in mortality (0.9% vs. 1.1%), 30-day readmissions (10.5% vs. 11.9%), or postoperative outcomes between matched patients treated at flagship versus non-flagship facilities (p > 0.05).</p><p><strong>Conclusions: </strong>There are no differences in perioperative outcomes between flagship and non-flagship hospitals in a given system in NYS. Patients with resectable non-metastatic colorectal cancer may not need to undergo oncologic resection at flagship hospitals to receive high-quality perioperative care.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.27949","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hospitals are rapidly consolidating to create large healthcare systems. Whether outcomes following colorectal cancer resection at flagship hospitals differ from those at non-flagship hospitals is unknown.

Methods: A 6-year retrospective analysis of an all-payor New York State (NYS) hospital database was conducted. All adult patients with a colorectal resection for primary resectable colorectal cancer were included. Within each system, the hospital with the most colorectal resections was designated the "flagship" hospital. Thirty-day outcomes at flagship facilities were compared to affiliated, non-flagship hospitals following colorectal resection while matching for patient-level differences.

Results: In total, 28 400 patients were included across 31 healthcare systems in NYS. There were no differences in mortality (0.9% vs. 1.1%), 30-day readmissions (10.5% vs. 11.9%), or postoperative outcomes between matched patients treated at flagship versus non-flagship facilities (p > 0.05).

Conclusions: There are no differences in perioperative outcomes between flagship and non-flagship hospitals in a given system in NYS. Patients with resectable non-metastatic colorectal cancer may not need to undergo oncologic resection at flagship hospitals to receive high-quality perioperative care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.70
自引率
4.00%
发文量
367
审稿时长
2 months
期刊介绍: The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.
期刊最新文献
About the Cover. Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients. Predictors Based on the Radiologic Characteristics for Aggressiveness of Small (< 20 mm) Nonfunctioning Pancreatic Neuroendocrine Tumors. Addressing Breast Cancer Disparities: A Comprehensive Approach to Health Equity. Letter to "Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1